WebMD's Misleading Results

The quarterly numbers would suggest that WebMD (Nasdaq: HLTH  ) is sending out healthy signals. But is it? Should we call a doctor?

For the fourth quarter of 2004, the company reported a 19% increase in revenue and an 87% jump in net income over 2003's fourth quarter. Going forward, the company upped its 2005 guidance for first-quarter revenue by $7 million and said earnings per share will be one penny higher -- $0.02-$0.03.

Although the numbers do look good, a careful examination provides a somewhat different diagnosis. Total sales for the fourth quarter increased $49.2 million, but $33.9 million of that increase (69%) came from customers acquired in recent acquisitions. As in previous quarters, acquisitions -- not organic growth -- provided the double-digit percentage growth at the top line.

The company likes to trumpet its $620 million in cash, short-term investments, and long-term marketable debt securities, but it doesn't give equal billing to its $650 million in convertible subordinated notes. Either the company is not as cash-rich as it looks (if it ends up repaying the convertibles), or there's going to be a lot of shareholder dilution (if the notes are converted to shares).

Using the company's 2005 net income guidance of $0.15 to $0.18 a share, the company's stock is selling for a heart-pumping 42 times forward earnings -- and that's based on the high end of guidance.

Investors have plenty of health-industry companies to consider. Bigger names include McKesson (NYSE: MCK  ) , Cerner (Nasdaq: CERN  ) , NDCHealth (NYSE: NDC  ) , Quality Systems (Nasdaq: QSII  ) , and Per-Se Technologies (Nasdaq: PSTI  ) . WebMD is getting healthier (hey, the company is making money), but given the stock's high valuation -- at least based on forward EPS -- this observer doesn't see any reason for it to post market-beating returns in the coming year.

Are you looking for value-priced stocks? Why not take a free trial to theMotley Fool Inside Valuenewsletter?

Fool contributor W.D. Crotty does not own shares in any of the companies mentioned. Clickhereto see the Motley Fool's disclosure policy.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 490872, ~/Articles/ArticleHandler.aspx, 10/28/2016 9:55:47 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,228.71 59.03 0.32%
S&P 500 2,135.75 2.71 0.13%
NASD 5,202.98 -13.00 -0.25%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/28/2016 9:39 AM
CERN $57.95 Up +0.19 +0.33%
Cerner CAPS Rating: ****
HLTH.DL $0.00 Down +0.00 +0.00%
HLTH Corp CAPS Rating: ***
MCK $119.34 Down -41.17 -25.65%
McKesson CAPS Rating: *****
PSTI $1.60 Down +0.00 +0.00%
Pluristem Therapeu… CAPS Rating: *
QSII $12.36 Down -0.02 -0.16%
Quality Systems CAPS Rating: ****